Go Pro
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Q1 2026 Earnings Report

Fresenius Medical Care AG & Co. KGaA logo
$22.70 +0.35 (+1.54%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$22.68 -0.01 (-0.04%)
As of 09/25/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fresenius Medical Care AG & Co. KGaA EPS Results

Actual EPS
$1.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fresenius Medical Care AG & Co. KGaA Revenue Results

Actual Revenue
$5.34 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fresenius Medical Care AG & Co. KGaA Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Fresenius Medical Care AG & Co. KGaA's Q3 2026 earnings is estimated for Tuesday, November 3, 2026, based on past reporting schedules, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Fresenius Medical Care AG & Co. KGaA Earnings Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Fresenius Medical Care AG & Co. KGaA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care AG & Co. KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care AG & Co. KGaA and other key companies, straight to your email.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a Germany-based health care company focused on kidney disease and dialysis services. The company provides hemodialysis and peritoneal dialysis treatments through a global network of outpatient dialysis clinics and supports patients with related care and medical services.

In addition to operating dialysis centers, Fresenius Medical Care develops and manufactures products used in renal care. Its portfolio includes dialysis machines, dialyzers, bloodlines, concentrates, solutions, pharmaceuticals and other disposable supplies. The company also offers clinical care, laboratory services and health care solutions connected with chronic kidney disease management.

Fresenius Medical Care was established in 1996 through the combination of Fresenius’s dialysis business with National Medical Care. Headquartered in Bad Homburg, Germany, the company serves patients and health care providers across North America, Europe, Asia-Pacific, Latin America and other international markets. Helen Giza serves as chief executive officer.

View Fresenius Medical Care AG & Co. KGaA Profile